GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (LSE:POLB) » Definitions » Land And Improvements

Poolbeg Pharma (LSE:POLB) Land And Improvements : £0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma Land And Improvements?

Poolbeg Pharma's land and improvements for the quarter that ended in Dec. 2024 was £0.00 Mil.


Poolbeg Pharma Land And Improvements Historical Data

The historical data trend for Poolbeg Pharma's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Land And Improvements Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Land And Improvements
- - - -

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Land And Improvements Get a 7-Day Free Trial - - - - -

Poolbeg Pharma Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


Poolbeg Pharma Business Description

Traded in Other Exchanges
Address
42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines